oncolytics biotech inc
(ONC:Toronto Stock Exchange)
Daniel Douglas Von Hoff M.D., F.A.C.P.
Consultant, Oncolytics Biotech Inc.
|Age||Total Calculated Compensation||This person is connected to 592 board members in 59 different organizations across 84 different industries.|
See Board Relationships
Dr. Daniel Douglas Von Hoff, also known as Dan, M.D., F.A.C.P., serves as a Senior Advisor of Clinical Development at Tolero Pharmaceuticals, Inc. and served as its Senior Vice President of Clinical Development. Dr. Von Hoff has been Senior Vice President of Medical Affairs at Lorus Therapeutics Inc., since October 28, 2013. He co-founded Cylene Pharmaceuticals, Inc. in 1998 and serves as its Senior Vice President of Medical Affairs. He serves as the Chief Scientific ...
1167 Kensington Crescent NWPhone: 403-670-7377
Calgary, Alberta T2N 1X7
Board Members Memberships*
Co-Founder, Senior Vice President of Medical Affairs, Director and Member of Scientific Advisory Board
Former Member of Scientific Advisory Board
Co-Founder, Chief Medical Officer and Director
Chief Scientific Officer and Director
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Carroll College (Montana)
Columbia University College of Physicians & Surgeons in New York
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|